Document is current
Any future updates will be listed below
-
Authors
Miranda, Antonio M. A. https://orcid.org/0000-0003-4281-614X
McAllan, Liam
Mazzei, Guianfranco
Andrew, Ivan
Davies, Iona
Ertugrul, Meryem
Kenkre, Julia
Kudo, Hiromi
Carrelha, Joana
Patel, Bhavik
Newton, Sophie
Zhang, Weihua https://orcid.org/0000-0001-8279-3611
Pollard, Alice
Cross, Amy
McCallion, Oliver
Jang, Mikyung
Choi, Ka Lok
Brown, Scarlett
Rasool, Yasmin
Adamo, Marco
Elkalaawy, Mohamed
Jenkinson, Andrew
Mohammadi, Borzoueh
Hashemi, Majid
Goldin, Robert https://orcid.org/0000-0001-5184-4519
Game, Laurence
Hester, Joanna
Issa, Fadi https://orcid.org/0000-0002-8279-7732
Ryan, Dylan G. https://orcid.org/0000-0003-4553-9192
Ortega, Patricia
Ahmed, Ahmed R.
Batterham, Rachel L. https://orcid.org/0000-0002-5477-8585
Chambers, John C.
Kooner, Jaspal S. https://orcid.org/0000-0003-2086-4837
Baranasic, Damir https://orcid.org/0000-0001-5948-0932
Noseda, Michela https://orcid.org/0000-0002-9553-5029
Tan, Tricia https://orcid.org/0000-0001-5873-3432
Scott, William R. https://orcid.org/0000-0001-5467-114X
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 3 June 2025
First Online: 9 July 2025
Competing interests
: R.L.B. participated in committees or advisory boards for ViiV Healthcare, Gila Therapeutics, Novo Nordisk, Pfizer, Eil Lilly, the Royal College of Physicians, NHS England, the National Institute for Health and Care Excellence, the British Obesity and Metabolic Surgery Society, the National Bariatric Surgery Registry, the Association for the Study of Obesity, the Obesity Health Alliance, the International Federation for the Surgery for Obesity and Metabolic Diseases, Obesity Empowerment Network UK and the European Society for Endocrinology. R.L.B. has undertaken consultancy work for Novo Nordisk, ViiV Healthcare and Epitomee Medical, and is employed by Eli Lilly. The remaining authors declare no competing interests.
